SA
Sign upLog In
IKT

IKT Operating Expenses

$65.81MTTM · USD

Period ending:

QuarterlyTTMAnnualChart Studio →
IKT FY Operating ExpensesUSD
IKT FY Operating Expenses2016-12-31: $734.29K2017-12-31: $2.47M2018-12-31: $2.12M2019-12-31: $4.27M2020-12-31: $2.62M2021-12-31: $6.51M2022-12-31: $18.25M2023-12-31: $6.73M2024-12-31: $28.56M2025-12-31: $51.97M$51.97M$0.00
2016-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

IKT operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.

Inhibikase Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
51,974,283
28,562,796
6,731,944
18,245,325
6,507,641
2,623,158
4,268,177
2,122,121
2,466,067
734,287

Compare operating expenses

All IKT financial metrics · IKT stock overview · How to interpret financial metrics

Explore More

Stock Comparison

Compare equities side by side

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.